Covaxin Shows 77.8% Efficacy against Symptomatic Covid Cases; 65.2% Efficacy against Delta Variant
Bharat Biotech India Ltd (BBIL), the Hyderabad-headquartered biotech major, has brought out the much-awaited phase-III results of Covaxin that engaged […]






